%22%20transform%3D%22translate(2.1%202.1)%20scale(4.21875)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%232d2d2d%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-99.77964%2052.27289%20-21.85774%20-41.72253%2066.7%2095.6)%22%2F%3E%3Cellipse%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-.66778%2033.11543%20-88.11482%20-1.77686%20181.9%20132.7)%22%2F%3E%3Cellipse%20cx%3D%22130%22%20cy%3D%2214%22%20rx%3D%22255%22%20ry%3D%2223%22%2F%3E%3Cellipse%20fill%3D%22%23292929%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(4.68895%20-27.14612%2093.5132%2016.15253%20184.1%2071.6)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
by G-Pact | Sep 29, 2017 | Information, Legislative News
9/29/17 PRESS RELEASE HEARING: #SubHealth to Review Patient Access to Investigational Drugs NEXT WEEK https://energycommerce.house.gov/news/press-release/hearing-subhealth-review-patient-access-investigational-drugs-next-week/ WASHINGTON, DC – The Subcommittee on...
